Speakers
 

Esther Babady, PhD, D (ABMM)

Memorial Sloan Kettering Cancer Center, New York, NY

Esther Babady, Ph.D., D (ABMM), is the Director of Clinical Operations for the Microbiology Laboratory Service, Director of the CPEP Clinical Microbiology Fellowship program and an associate attending in the Department of Laboratory Medicine at Memorial Sloan-Kettering Cancer (MSKCC) in New York City. She received her PhD in Biochemistry and Molecular Biology and completed a post-doctoral CPEP fellowship in Clinical Microbiology both at the Mayo Clinic in Rochester, MN before joining MSKCC. She serves on the editorial boards of several journals (JCM, JMD, JCV and CMR) and society leadership councils and committees including PASCV, ASM and AMP. Her research interests include the development and evaluation of rapid molecular tests for the diagnosis of infections in immunocompromised hosts and applications of molecular tests for the surveillance of hospital acquired infections.

 

Disclosures: This research was sponsored by Roche Molecular Diagnostics, GenMark Diagnostics and Luminex Corp. I received honoraria from Roche Molecular Diagnostics.

 

Ellen Jo Baron, PhD
Professor Emerita, Stanford University, Stanford, CA
Formerly Ex. Dir. Medical Affairs, Cepheid, Sunnyvale, CA

Ellen Jo Baron, Stanford University Professor of Pathology Emerita, directed diagnostic microbiology and virology laboratories for over 35 years, most recently at Stanford Medical Center in California. She wrote or edited several major reference books, including the American Society for Microbiology’s Manual of Clinical Microbiology, 7th, 8th, and 9th editions. In 2007 she developed a visually-based basic training course aimed at enhancing diagnostic microbiology capacity in resource-poor areas; and since then the materials have been used around the world. The non-governmental organization she co-founded in 2008, Diagnostic Microbiology Development Program, continues to support laboratory capacity improvement in resource-poor areas of the world, currently focused in Cambodia. She joined the molecular diagnostics company Cepheid in 2008 and retired as Executive Director of Medical Affairs in 2018. In 1997 she received the ASM Alice Evans Award (womens’ leadership), the BioMerieux Sonnenwirth Award for Leadership in Clinical Microbiology in 2000, and the ASM Founders’ Award in 2012. She received several teaching awards at Stanford, and was honoured with the Lifetime Achievement Award from the Anaerobe Society of the Americas in 2018.

 

Disclosures: I am a paid consultant/employee for Cepheid. The following product discussed is not labeled for the use of under discussion or is still investigational: Xpert HPV by Cepheid is not FDA cleared in the US. It is CE marked.

 

Angela M. Caliendo, MD, PhD
Warren Alpert Medical School of Brown University, Providence, RI

Angela M. Caliendo, MD, PhD is Professor, Executive Vice Chair of the Department of Medicine at the Warren Alpert Medical School of Brown University. Dr. Caliendo received a PhD (Biochemistry) and MD from Case Western Reserve University School of Medicine and completed an internship and residency in Internal Medicine at Brigham and Women’s Hospital in Boston, MA and an Infectious Diseases fellowship at Massachusetts General Hospital, Boston MA. Prior to joining the faculty at Brown, she was Professor and Vice Chair of Pathology at Emory University School of Medicine, the Director of Emory Medical Laboratories, and the Medical Director of Clinical Microbiology and Molecular Diagnostics Laboratories.

Dr. Caliendo’s research has focused on the development of molecular diagnostic tests for the detection and quantification of infectious diseases and assessment of their clinical utility; molecular testing in transplantation; standardization of viral load testing; and evaluation of HIV-1 RNA burden and the development of antiretroviral resistance in HIV-1 seropositive women.

Dr. Caliendo is an Editor for the Journal of Clinical Microbiology and member of the Board of Directors for the Infectious Diseases Society of America, a Fellow of the Infectious Diseases Society of America and the American Academy of Microbiology. Previously she chaired the Microbiology Medical Devices Panel for the FDA, the Diagnostics Task Force for the Infectious Diseases Society of America, served as the President of the Association of Molecular Pathology (2004), and President of the Pan-American Society for Clinical Virology (2010 -2012). Dr. Caliendo has published over 150 peer-reviewed manuscripts covering various topics in clinical and diagnostic virology and microbiology and was a recent recipient of the Ed Nowakowski Senior Memorial Clinical Virology Award from the Pan American Society for Clinical Virology and the BD Award for Research in Clinical Microbiology from the American Society for Microbiology.

 

Disclosures: This research was sponsored by ArcBio. I am a Scientific Advisor: Roche Molecular, Quidel, Luminex, Day Zero.

 

Ana Maria Cardenas, PhD, D(ABMM)
Becton Dickinson, Sparks, MD

Ana María Cárdenas is Microbiology R&D Senior Manager with BD and is a Diplomate of the American Boards of Medical Microbiology. Before joining BD, she was Assistant Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and served as Director of the Infectious Disease Diagnostics Laboratory at the Children’s Hospital of Philadelphia. 


Dr. Cárdenas received her doctorate in Molecular Virology and Microbiology from Baylor College of Medicine and subsequently completed a fellowship in Medical and Public Health Microbiology at the University of Pennsylvania.

Dr. Cárdenas is currently a Council Member of the Pan-American Society for Clinical Virology and is an active member of several committees for both ASM and CLSI. She is interested in value-based approaches to diagnostic testing that impact laboratory efficiency and clinician utilization.

 

Disclosures: I am a paid consultant/employee for Becton, Dickinson and Company.

 

Marcela Ferres, MD, MPH
Pontificia Universidad Catolica de Chile, Santiago, Chile

Marcela Ferres, MD, MPH is a pediatric Infectious disease subspecialist, professor at medical school, P Universidad Catolica Chile. She teaches under and postgraduate medical students and is in charge of the Diagnostic Virology Laboratory for the last 28 years at Red de Salud UC CHRISTUS. Her primary clinical and research interests are viral infections in immune-suppressed patients and emerging viral infections like hantavirus. She is an active member of PASCV for the last 25 years and is currently serving as Latin American council.


Dr. Ferres obtained her medical degree at Universidad de Chile, and did her pediatric residency at P Universidad Catolica de Chile, after that she completed a Master in Epidemiology and Public Health at EPH, Yale University and a fellowship in pediatric infectious disease at Yale University School of Medicine.

 

Disclosures: Nothing to disclose.

 

Richard L. Hodinka, PhD

University of South Carolina School of Medicine Greenville and PRISMA Health System, Greenville, SC

Dr. Hodinka received his B.S. in Biology from Marietta College, Marietta, OH in 1976, his M.S. in Microbiology in 1979 from the University of Montana, Missoula, MT, and his Ph.D. in Microbiology from Ohio University, Athens, OH in 1983. He then completed a research postdoctoral fellowship (1983-86) in Microbiology in the Department of Microbiology & Immunology at the University of North Carolina, Chapel Hill, NC followed by a clinical postdoctoral fellowship (1986-88) in Medical and Public Health Laboratory Microbiology at the University of North Carolina Medical Center, Chapel Hill, NC.


Dr. Hodinka joined the faculty of the Perelman School of Medicine at the University of Pennsylvania in 1988 where he was a Professor of Pathology and Laboratory Medicine and Director of the Clinical Virology Laboratory at Children’s Hospital of Philadelphia until his retirement from these institutions in June of 2014. He joined the founding faculty of the USC School of Medicine Greenville in July of 2014 and is currently a Professor in Microbiology and the Chair of the Department of Biomedical Sciences. He
provides instruction in medical microbiology and infectious diseases at the USC School of Medicine Greenville and conducts clinical sciences/translational research through the Greenville Health System and the University of South Carolina.


He has served as the co-organizer of the Clinical Virology Symposium since 1994 and was co-organizer of the Molecular Virology Workshop from 1994-2013. Both meetings have received international acclaim as forums for the meaningful exchange of ideas dealing with human viral infections. Dr. Hodinka has also served as President and a Council Member for the Pan American Society for Clinical Virology (PASCV) and as a member of the International Scientific Advisory Committee for the Asia Pacific Congress of Medical Virology. He has been a member of the American Society for Microbiology (ASM) since 1978 and has served on a number of societal committees and in various capacities for this organization. He has also organized and participated in a number of ASM Workshops, Sunrise Sessions, Symposia, Colloquia, and Webinars over his career.


Dr. Hodinka serves as an invited reviewer for a number of journals and is on various journal editorial boards, including the Editorial Boards for the Journal of Clinical Microbiology, Journal of Clinical and Vaccine Immunology, and the Journal of Clinical Virology (currently an Editor). He also participates as a scientific reviewer of grants and is a member on national and international committees, working groups, and advisory boards as an expert in his field. His clinical and research interests involve pediatric viral diseases, detection and monitoring of viral infections in pediatric and adult immunocompromised hosts, and the development and study of rapid and accurate methods for the diagnosis of infectious diseases; current emphasis is on molecular technologies and automated instrumentation for the greatest impact on the care and management of ill patients. He has published extensively and is the author of a number of original scientific publications, review articles and book chapters, and is an Editor of a well-respected book in laboratory medicine titled the Clinical Virology Manual. Dr. Hodinka has been recognized for his excellence in teaching and research. His awards include election to Fellowship in the American Academy of Microbiology, the PASCV Diagnostic Virology Award received in recognition of his contributions to the field of diagnostic virology, the PASCV Dupont Clinical Virology Young Investigator Award, the 2016 bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology, as well as 2 Distinguished Teaching Awards and the Dean's Award for Excellence in Basic Science Teaching from the Perelman School of Medicine at the University of Pennsylvania and the 2018 Biomedical Sciences Faculty Teacher of the Year at the USC School of Medicine Greenville. He is in demand as a speaker at academic institutions and at national and international conferences and has served as a National Foundation Lecturer for the American Society for Microbiology and is currently a member of the American Society for Microbiology Speakers’ Bureau.

 

Disclosures: Nothing to disclose.

 

Jorge L. Munoz-Jordan, PhD
Centers for Disease Control and Prevention, San Juan, Puerto Rico

Dr. Jorge L. Munoz works has held the position of Laboratory Lead at Dengue Branch of the Centers for Disease Control and Prevention for 15 years. Dr. Munoz has a PhD from The Rockefeller University, New York. Prior to his position at the CDC, he worked on Dengue, Influenza and Ebola at the Mount Sinai School of Medicine, and on Trypanosomiasis at the Rockefeller University in New York. This is in addition to previous experience in tropical diseases in Latin America. Dr. Munoz-Jordan oversees research and diagnostic areas of a national and international reference laboratory, and a PAHO/WHO reference center. He has published more than 100 peer-reviewed articles, including 4 book chapters, and has been invited reviewer and advisor for numerous working groups globally. Dr. Munoz has developed high throughput molecular diagnostic tests in multiplex formats that can detect the 4 four dengue virus subtypes or differentiate between Zika, dengue and chikungunya viruses in patients.

 

Disclosures: Nothing to disclose.

 

Juan Miguel Pascale, MD, PhD
Gorgas Memorial Institute, Panamá, Panama

Dr. Pascale is a physician, graduated from University of Panamá. Has a Masters Degree in Biomedical Sciences from the Karolinska Institute, Stockholm, Sweden and a PhD in Pathology from the University of Indiana. Currently, is the Director of the Gorgas Memorial Institute for Health Studies and Immunology professor at the Med School of the University of Panama. Has more than 78 scientific publications on indexed journals, most of them in the infectious diseases and STDs. He has been advisor for multiple doctorate and master´s degree student thesis at the University of Panama and universities outside Panama. Prominent member of the National Research System and was distinguished with the William C. Gorgas medal of honor and the Excellence in Research Award by the Panamanian Society for Science Development (APANAC) and the Secretary of Science (SENACYT).

 

Disclosures: Presentation is supported by Roche.

 

Ryan F. Relich, PhD, D(ABMM), MLS(ASCP)SM
Indiana University School of Medicine, Indianapolis, IN

Dr. Relich is a board-certified clinical microbiologist who is passionately interested in all facets of diagnostic microbiology and laboratory medicine, especially the development of novel diagnostics, including those for high-consequence pathogens, laboratory directorship, infectious disease epidemiology and pathology, and emerging virus ecology and discovery. In his current academic position at the Indiana University (IU) School of Medicine, he is actively involved in fellow, resident, and student teaching, and research involving in vitro diagnostic product development and clinical trials, and, most recently, the ecology of emerging zoonotic viruses such as Heartland virus, Bourbon virus, hantaviruses, and many others. As an employee of IU Health, Dr. Relich serves as the Medical Director of the IU Health Special Pathogens Unit Laboratory, Associate Medical Director of the Divisions of Clinical Microbiology and Molecular Pathology, and Section Director of Clinical Virology. Dr. Relich also serves as Section Director, Clinical Microbiology and Serology for Eskenazi Health, a community healthcare system located in central Indiana. He is immensely interested in pandemic preparedness, novel virus discovery and characterization, and establishing best practices for manipulating highly infectious clinical specimens such as those from Ebola patients, among many other things.

 

Disclosures: I am a paid consultant/employee for NaviDx Consulting. I received honoraria from
Illinois Society for Microbiology BioFire Diagnostics.

 

  Meghan Starolis, MS, PhD
Quest Diagnostics, Chantilly, VA

Dr. Meghan Starolis currently serves as Scientific Director of Molecular Infectious Disease as Quest Diagnostics. Her fields of interest include chronic viral diseases, infectious disease related to transplantation, women’s health, and emerging infectious disease. Previously, she has done research at the FDA (CBER) and her graduate research focused on molecular pathways for biofilm formation in Francisella tularensis.

 

Disclosures: I am a paid consultant/employee for Quest Diagnostics.


Association Management Software Powered by YourMembership  ::  Legal